Mamilla, Marcos M.
HRN: 20-99-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/29/2022
10/05/2022
IV
1.5g
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes